search
Back to results

Two Week Cross-Over Study Comparing Two Daily Disposable Contact Lenses

Primary Purpose

Myopia

Status
Completed
Phase
Not Applicable
Locations
Singapore
Study Type
Interventional
Intervention
etafilcon A
omafilcon A
Sponsored by
Johnson & Johnson Vision Care, Inc.
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Myopia

Eligibility Criteria

18 Years - 39 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • At least 18 years of age and no more than 39 years of age
  • Existing soft contact lens wearers
  • Willing to signed a written Informed Consent.
  • Own a mobile phone and are willing to receive and reply to Short Message Service (SMS) messages during the day.
  • Have a contact lens spherical distance requirement between -1.00 diopters (D) and -6.00 diopters (D) in both eyes.
  • Have an Astigmatism of 1.00D or less in both eyes.
  • Require a visual correction in both eyes.
  • Be correctable to a visual acuity of 6/9 (20/30) or better in each eye.
  • Have normal eyes with no evidence of abnormality or disease that would preclude lens wear.

Exclusion Criteria:

  • Clinically significant (Grade 3 or 4) corneal edema, corneal vascularization, tarsal abnormalities, bulbar infection, or any other abnormality of the cornea that would contraindicate contact lens wear.
  • Clinically significant corneal staining (Grade 3 in more than one region).
  • Keratoconus or other corneal irregularity.
  • Abnormal lachrymal secretions.
  • Extended wear of contact lenses last 3 months.
  • Polymethyl methacrylate (PMMA) or rigid gas-permeable (RGP) lens wear in the previous 8 weeks.
  • Refractive surgery.
  • Eye injury/surgery within 8 weeks immediately prior to enrollment for this study.
  • Pre-existing ocular irritation that would preclude contact lens fitting.
  • Require concurrent ocular medication
  • Any systemic illness which would contraindicate lens wear or the medical treatment of which would affect vision or successful lens wear.
  • Any infectious disease (e.g., hepatitis, tuberculosis) or any immunosuppressive disease (e.g., HIV).
  • Diabetes.
  • Pregnant, lactating or planning a pregnancy at the time of enrollment.
  • Participation in any concurrent clinical trial or in last 30 days.

Sites / Locations

  • Singapore Plytechnic

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

etafilcon A/omafilcon A

omafilcon A/etafilcon A

Arm Description

etafilcon A contact lenses will be worn during the first week and omafilcon A contact lenses will be worn during the second. Lenses were replaced daily

omafilcon A contact lenses will be worn during the first week and etafilcon A contact lenses will be worn during the second. Lenses were replaced daily.

Outcomes

Primary Outcome Measures

Subjective Rating of Comfort
This outcome is a weighted combined score calculated from individual comfort-related questions asked on a 1-5 scale: 1 = most negative response to 5 = most positive response.
Vision Quality
This outcome is a weighted combined score calculated from individual vision-related questions asked on a 1-5 scale: 1 = most negative response to 5 = most positive response.
Subjective Rating of Handling
This outcome is a weighted combined score calculated from individual lens handling-related questions asked on a 1-5 scale: 1 = most negative response to 5 = most positive response.
Corneal Staining
Investigator assessment of the corneal staining. Staining is an indication of dryness on areas on the cornea. Here it is measured over 5 regions of the cornea: central, temporal, nasal, inferior, and superior. The staining is graded using the National Eye Institute (NEI)0-3 scale: grade 0 = normal, grade 1 = mild, grade 2 = moderate, grade 3 = severe.
Subjective Rating of Quality Perceptions
This outcome is a weighted combined score calculated from individual quality perception-related questions asked on a 1-5 scale: 1 = most negative response to 5 = most positive response.
Limbal Hyperemia
This outcome is assessed by the investigator during biomicroscopy examination using the following 0-4 scale: 0 = none, 1 = trace, 2 = mild, 3= moderate, 4 = severe.

Secondary Outcome Measures

Full Information

First Posted
June 30, 2010
Last Updated
June 18, 2018
Sponsor
Johnson & Johnson Vision Care, Inc.
Collaborators
Johnson & Johnson K.K. Medical Company, Visioncare Research Ltd.
search

1. Study Identification

Unique Protocol Identification Number
NCT01155323
Brief Title
Two Week Cross-Over Study Comparing Two Daily Disposable Contact Lenses
Official Title
Proclear 1 Day Lens vs 1-Day Acuvue Moist Daily Disposable Contact Lens Crossover Study
Study Type
Interventional

2. Study Status

Record Verification Date
August 2017
Overall Recruitment Status
Completed
Study Start Date
March 1, 2010 (Actual)
Primary Completion Date
June 1, 2010 (Actual)
Study Completion Date
June 1, 2010 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Johnson & Johnson Vision Care, Inc.
Collaborators
Johnson & Johnson K.K. Medical Company, Visioncare Research Ltd.

4. Oversight

5. Study Description

Brief Summary
This study seeks to evaluate and compare the clinical performance of two daily disposable soft contact lenses, Proclear 1 Day and 1-Day Acuvue Moist.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Myopia

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
Participant
Allocation
Randomized
Enrollment
118 (Actual)

8. Arms, Groups, and Interventions

Arm Title
etafilcon A/omafilcon A
Arm Type
Active Comparator
Arm Description
etafilcon A contact lenses will be worn during the first week and omafilcon A contact lenses will be worn during the second. Lenses were replaced daily
Arm Title
omafilcon A/etafilcon A
Arm Type
Active Comparator
Arm Description
omafilcon A contact lenses will be worn during the first week and etafilcon A contact lenses will be worn during the second. Lenses were replaced daily.
Intervention Type
Device
Intervention Name(s)
etafilcon A
Intervention Description
1-day soft contact lens
Intervention Type
Device
Intervention Name(s)
omafilcon A
Intervention Description
1-day soft contact lens
Primary Outcome Measure Information:
Title
Subjective Rating of Comfort
Description
This outcome is a weighted combined score calculated from individual comfort-related questions asked on a 1-5 scale: 1 = most negative response to 5 = most positive response.
Time Frame
after 1 week of lens wear
Title
Vision Quality
Description
This outcome is a weighted combined score calculated from individual vision-related questions asked on a 1-5 scale: 1 = most negative response to 5 = most positive response.
Time Frame
after 1 week of lens wear
Title
Subjective Rating of Handling
Description
This outcome is a weighted combined score calculated from individual lens handling-related questions asked on a 1-5 scale: 1 = most negative response to 5 = most positive response.
Time Frame
after 1 week of lens wear
Title
Corneal Staining
Description
Investigator assessment of the corneal staining. Staining is an indication of dryness on areas on the cornea. Here it is measured over 5 regions of the cornea: central, temporal, nasal, inferior, and superior. The staining is graded using the National Eye Institute (NEI)0-3 scale: grade 0 = normal, grade 1 = mild, grade 2 = moderate, grade 3 = severe.
Time Frame
after 1 week of lens wear
Title
Subjective Rating of Quality Perceptions
Description
This outcome is a weighted combined score calculated from individual quality perception-related questions asked on a 1-5 scale: 1 = most negative response to 5 = most positive response.
Time Frame
after 1 week of lens wear
Title
Limbal Hyperemia
Description
This outcome is assessed by the investigator during biomicroscopy examination using the following 0-4 scale: 0 = none, 1 = trace, 2 = mild, 3= moderate, 4 = severe.
Time Frame
after 1 week of wear

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
39 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: At least 18 years of age and no more than 39 years of age Existing soft contact lens wearers Willing to signed a written Informed Consent. Own a mobile phone and are willing to receive and reply to Short Message Service (SMS) messages during the day. Have a contact lens spherical distance requirement between -1.00 diopters (D) and -6.00 diopters (D) in both eyes. Have an Astigmatism of 1.00D or less in both eyes. Require a visual correction in both eyes. Be correctable to a visual acuity of 6/9 (20/30) or better in each eye. Have normal eyes with no evidence of abnormality or disease that would preclude lens wear. Exclusion Criteria: Clinically significant (Grade 3 or 4) corneal edema, corneal vascularization, tarsal abnormalities, bulbar infection, or any other abnormality of the cornea that would contraindicate contact lens wear. Clinically significant corneal staining (Grade 3 in more than one region). Keratoconus or other corneal irregularity. Abnormal lachrymal secretions. Extended wear of contact lenses last 3 months. Polymethyl methacrylate (PMMA) or rigid gas-permeable (RGP) lens wear in the previous 8 weeks. Refractive surgery. Eye injury/surgery within 8 weeks immediately prior to enrollment for this study. Pre-existing ocular irritation that would preclude contact lens fitting. Require concurrent ocular medication Any systemic illness which would contraindicate lens wear or the medical treatment of which would affect vision or successful lens wear. Any infectious disease (e.g., hepatitis, tuberculosis) or any immunosuppressive disease (e.g., HIV). Diabetes. Pregnant, lactating or planning a pregnancy at the time of enrollment. Participation in any concurrent clinical trial or in last 30 days.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Danny Sim, Diploma in Optometry
Organizational Affiliation
Singapore Polytechnic
Official's Role
Principal Investigator
Facility Information:
Facility Name
Singapore Plytechnic
City
Singapore
ZIP/Postal Code
139651
Country
Singapore

12. IPD Sharing Statement

Learn more about this trial

Two Week Cross-Over Study Comparing Two Daily Disposable Contact Lenses

We'll reach out to this number within 24 hrs